STAAR, a phase I/II study of isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Dose escalation phase results

被引：0
|
作者：
Hopkin, Robert J. [1 ]
Ganesh, Jaya [2 ]
Deegan, Patrick [3 ]
Goker-Alpan, Ozlem [4 ]
Bernat, John [5 ]
Wilcox, William R. [6 ]
Pahl, Madeleine V. [7 ]
Whitley, Chester B. [8 ]
Hughes, Derralynn [9 ]
Nicholls, Kathleen [10 ]
Cao, Liching [11 ]
Chen, Michael [11 ]
Shiue, Lisa H. [11 ]
Bowden, Emma [11 ]
Jaggumantri, Sravan [11 ]
Passalacqua, Cristobal [11 ]
Souberbielle, Bernard [11 ]
Cockroft, Bettina M. [11 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
[3] Addenbrookes Hosp, Cambridge, England
[4] Lysosomal & Rare Disorders Res & Treatment Ctr In, Fairfax, VA USA
[5] Univ Iowa, Iowa City, IA USA
[6] Emory Univ, Human Genet, Atlanta, GA USA
[7] Univ Calif Irvine, Orange, CA USA
[8] Univ Minnesota, Minneapolis, MN USA
[9] UCL, London, England
[10] Royal Melbourne Hosp, Parkville, Australia
[11] Sangamo Therapeut Inc, Brisbane, CA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2022.107152
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
169
引用
收藏
页码：61 / 62
页数：2
相关论文
共 50 条
  • [1] Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
    Hughes, Derralynn
    Wilcox, William
    Hopkin, Robert J.
    Ganesh, Jaya
    Bernat, John
    Goker-Alpan, Ozlem
    Nicholls, Kathy
    Deegan, Patrick
    Pahl, Madeleine
    Whitley, Chester B.
    Chen, Michael
    Cao, Liching
    Schreeb, Katharina H.
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02)
  • [2] Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
    Hopkin, Robert J.
    Ganesh, Jaya
    Bernat, John
    Goker-Alpan, Ozlem
    Nicholls, Kathleen
    Pahl, Madeleine V.
    Deegan, Patrick B.
    Whitley, Chester B.
    Hughes, Derralynn
    Cao, Liching
    Chen, Michael
    Shiue, Lisa
    Rojkjaer, Lisa
    Wilcox, William R.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [3] Preliminary results of STAAR, a Phase I/II study of isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease and long-term follow-up
    Deegan, P.
    Ganesh, J.
    Goker-Alpan, O.
    Hopkin, R.
    Bernat, J.
    Wilcox, W.
    Cao, L.
    Chen, M.
    Shiue, L.
    Bowden, E.
    Jaggumantri, S.
    Passalacqua, C.
    Souberbielle, B.
    Cockroft, B.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A9 - A10
  • [4] A 3-month gene therapy single-dose IV administration pharmacology and safety study with ST-920 (isaralgagene civaparvovec) for Fabry disease in mice
    Meyer, Kathleen E.
    Lorget, Florence
    Prawdzik, Gregg
    Falaleeva, Marina
    Cao, Liching
    Falese, Lillian
    Huston, Marshall W.
    Hettini, Khaled
    Lu, Yanmei
    Ledeboer, Annemarie
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [5] A phase I/II multicenter gene therapy clinical study for Fabry disease
    Hughes, Derralynn
    Goker-Alpan, Ozlem
    Ganesh, Jaya
    Lau, Heather
    Foo, Cheryl Wong Po
    Souberbielle, Bernard
    Woolfson, Adrian
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S77 - S77
  • [6] A phase I/II multicenter gene therapy clinical study for Fabry disease
    Ganesh, Jaya
    Goker-Alpan, Ozlem
    Jaggumantri, Sravan
    Souberbielle, Bernard
    Cockroft, Bettina
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S41 - S42
  • [7] Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial
    MacLaren, Robert E.
    Xue, Kanmin
    Barnard, Alun R.
    Patricio, Maria Ines
    Edwards, Thomas L.
    Downes, Susan
    Lotery, Andrew
    Black, Graeme
    Webster, Andrew
    Jolly, Jasleen K.
    Seabra, Miguel C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [8] Analysis of Gb3 inclusions in kidney biopsies as a biomarker supporting the ST-920 phase 1/2 clinical trial for Fabry disease
    Cheung, Ruby
    Cao, Liching
    Sinclair, Elena
    Meyer, Kathleen
    Lu, Yanmei
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [9] Phase I/II dose escalation study with Carbon ions at NIRS
    Tsujii, H
    Miyamoto, T
    Mizoe, J
    Nakano, T
    Kamada, T
    Kato, H
    Matsuoka, Y
    Tsuji, H
    Abe, A
    Morita, S
    PHYSICA MEDICA, 1998, 14 : 70 - 75
  • [10] Phase I/II gene therapy study for Chronic Granulomatous Disease: Results, lessons and perspectives
    Ott, Marion G.
    Stein, Stefan
    Schultze-Strasser, Stephan
    Jauch, Anna
    Burwinkel, Barbara
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Preiss, Carolin
    Kramer, Rolf
    Schwarzwaelder, Kerstin
    Koehl, Ulrike
    Kunkel, Hanna
    Kuehlcke, Klaus
    Schilz, Andrea
    Schmidt, Manfred
    von Kalle, Christof
    Trasher, Adrian
    Hoelzer, Dieter
    Seger, Reinhard
    Grez, Manuel
    BLOOD, 2007, 110 (11) : 155A - 155A
12345